• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Exelixis

Related Topics

  1. First National
  2. ev3
  3. Patrick J. Powers
  4. Seattle Genetics
  5. Community Bancshares
  6. Giant Interactive Group

Popular Topics

  1. Eagle Bulk Shipping
  2. Volvo
  3. Consumer Price Index
  4. Labor Market
  5. Commodity Prices

Exelixis

Exelixis EXEL 5 Star

Last Price$4.55Day Change (%)0%
Open Price$4.57Day Change ($)0.00
Day Range4.53–4.6152-Week Range4.19–6.95

As of Fri 05/17/2013 06:23 PM EDT | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  1. Exelixis , Inc. EXEL Q2 2011 Earnings Call Transcript

    Good day, ladies and gentlemen, and welcome to the Second Quarter 2011 Exelixis Financial Results Conference Call. My name is Ann, and I will be your coordinator for today's call. As a reminder, this conference is being recorded for replay purposes. At this time, all participants are in a ...

  2. Beware 5-Star Stocks Bearing No Moats

    Lack of competitive advantages may mean these companies aren't the bargains they seem to be.

  3. Don't Bail on Biotech

    We see opportunity as fleeing investors trigger an irrational sell-off.

  4. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  5. Top 5 Rallying Biotech Stocks Being Snapped Up By Insiders

     

  6. Top Biotech Acquisition Candidates

    2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

  7. Biotech ETFs: Which One Is Best Now?

    The five biotech ETFs have very different portfolios with markedly different performance.

  8. Our Top Five Biotech Takeout Picks

    Health-care analyst Lauren Migliore looks at what makes a biotech firm a likely takeout candidate and reveals our top five biotech M&A picks for 2010.

  9. Our Top Five Biotech Acquisition Candidates

    M&A activity grew in 2010, and we expect deal volume to remain strong in 2011.

Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.